NCT01370863 - An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 2, 2010

Primary Completion Date

May 29, 2012

Study Completion Date

May 29, 2012

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG

SPD557

0.5 mg tablet t.i.d. for 4 weeks on top of stable PPI treatment

DRUG

placebo

matching placebo tablet t.i.d. for 4 weeks on top of stable PPI treatment

Trial Locations (15)

1070

CUB Hôpital Erasme, Brussels

1200

Cliniques universitaires Saint Luc, Brussels

3000

UZ Leuven, Belgium, Leuven

9007

Kantonsspital St. Gallen, Sankt Gallen

33075

CHU de Bordeaux - Hôpital Saint André, Bordeaux

39120

Otto-von-Guericke University, Magdeburg

44093

Hôtel Dieu - CHU de Nantes, Nantes

69437

CHU de Lyon - Groupement Hospitalier Edouard Herriot, Lyon

82467

Klinikum Garmisch-Partenkirchen GmbH, Garmisch-Partenkirchen

1105 AZ

Academisch Medisch Centrum (AMC), Amsterdam

BHH D140

Inselspital Bern (Bern University Hopsital), Bern

CH-8091

University Hospital Zurich, Zurich

CB2 0QQ

Addenbrooke's Hospital, Cambridge

E12AJ

Wingate Institute of Neurogastroenterology, London

NG7 2UH

Queen's Medical Center (Nottingham University Hospital), Nottingham